1-20 of 30
Ajay Major
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Healthcare Utilization Model Comparing Time Toxicity between Glofitamab and Epcoritamab

Pallawi Torka, Anthony Masaquel, Lourenia Cassoli, David Fox, Arliene Mangalindan, Ajay Major
Journal: Blood
Blood (2024) 144 (Supplement 1): 3647.
https://doi.org/10.1182/blood-2024-198476
Published: 2024
Journal Articles

The Predictive Value of Cell-of-Origin Subtype By Hans Algorithm in 718 Patients with Large B Cell Lymphoma Receiving Polatuzumab Vedotin

Edward R Scheffer Cliff, Guido D Pelaez, Fei Wan, Varun Iyengar, Jihao Zhou, Kevin Chung, Nayef Abdel-Razeq, Ajay Major, Jessica M Allen, John Sharp, Narendranath Epperla, Patrick Gould, Hua-Jay J Cherng, Samin Houshyar, Danielle S Wallace, Ryan C. Lynch, Avyakta Kallam, Matthew Mei, Reid W. Merryman, Michelle Fleyshman, Joanna M. Rhodes, Adam Kidwell, Timothy S Fenske, Erin Mulvey, Marcus P. Watkins, Muhamad Alhaj Moustafa, Talal Hilal, Grzegorz S. Nowakowski, Yucai Wang, Pallawi Torka, David A Russler-Germain
Journal: Blood
Blood (2024) 144 (Supplement 1): 652.
https://doi.org/10.1182/blood-2024-202153
Published: 2024
Journal Articles

TP53 -Altered Aggressive Large B-Cell Lymphoma (LBCL) Outcomes By Treatment Modality: A Multicenter Cohort from 14 U.S. Centers

Cassandra Duarte, Grace Bosma, Diana Abbott, Gaston Jean-Louis, Maciej Kabat, Daniel Stapor, Nancy Musoke, Brian T. Hill, Alexander Gorzewski, Tharakeswari Selvakumar, Asaad Trabolsi, Megan Greenberg, Alec Hansen, Neil Bailey, Mazyar Shadman, Ellen K Kendall, Nausheen Ahmed, Forat Lutfi, Patrick Connor Johnson, Mengyang Di, Krish Patel, Allison M. Bock, Joanna Rhodes, Jonathan H. Schatz, Brian Hess, Reem Karmali, Zachary AK Frosch, Andrew Ip, Hua-Jay J Cherng, Jagar Jasem, Steven M. Bair, Bradley M. Haverkos, Manali Kamdar, Ajay Major
Journal: Blood
Blood (2024) 144 (Supplement 1): 6451.
https://doi.org/10.1182/blood-2024-194844
Published: 2024
Journal Articles

Modeling Longitudinal Quality of Life Changes in Patients Diagnosed with Lymphomas: Heatmap Analysis of Electronic Patient-Reported Outcomes (ePRO) Data from the Bison-PRO Quality of Life Study

Vincenzo J Pizzuti, Kaitlyn Hoover, Jamie L Studts, Tyler W. Buckner, Benjamin Brewer, Ajay Major
Journal: Blood
Blood (2024) 144 (Supplement 1): 5133.
https://doi.org/10.1182/blood-2024-201110
Published: 2024
Journal Articles

Real-World Outcomes with Bispecific T-Cell Engagers (REALBiTE) for Relapsed or Refractory Large B-Cell Lymphoma: A Multi-Center, Retrospective Cohort Study

Taylor R. Brooks, Emily C. Zabor, Yohana B. Bedelu, Nikita Dave, Daniel J. Landsburg, Adrienne N. Nedved, Yucai Wang, Catherine Reinert, Ajay Major, Megan Sears-Smith, Nilanjan Ghosh, Kiarash Salafian, Emily Ayers, Jordan Miller, Natalie Grover, Chelsea Peterson, Cyrus Khan, Sean Patrick Bliven, Mayur S. Narkhede, Carrie I Ho, Stephen D. Smith, Alyssa Gibson, Justin Kline, Suchitra Sundaram, Joshua Brody, Kelsey Baron, Boyu Hu, Daniel Trotier, Priyanka A. Pophali, XI Yang, Yasmin H. Karimi, Marshall McKenna, Yun Kyoung Tiger, Alex Niu, Francisco Hernandez-Ilizaliturri, Rodolfo Garza Morales, Javier Munoz, Fadzai Chinyengetere, Sandeep Dave, Nayef Abdel-Razeq, Muhamad Alhaj Moustafa, Paolo F. Caimi, Brian T. Hill
Journal: Blood
Blood (2024) 144 (Supplement 1): 111.
https://doi.org/10.1182/blood-2024-199330
Published: 2024
Journal Articles

Vulnerable Elders Survey (VES-13) and Longitudinal Analysis of Quality of Life in Indolent Non-Hodgkin Lymphoma: A Multi-Institutional Prospective Cohort Study

Mazie Tsang, Brie N Noble, Carla Casulo, Carrie A Thompson, Allison C. Rosenthal, Dai Chihara, Eric Mou, Urshila Durani, Annalynn M Williams, Michelle A.T. Hildebrandt, Kathleen J Yost, Melissa C. Larson, Brianna Gysbers, Matthew J. Maurer, Andrew L. Feldman, David L. Jaye, Jon Tilburt, Ajay Major, Talal Hilal, Yucai Wang, Amber Koehler, Timothy G. Call, Sameer A. Parikh, Javier L. Munoz, Gita Thanarajasingam, Loretta Nastoupil, Grzegorz S. Nowakowski, Jonathon B. Cohen, Thomas M. Habermann, Christopher Strouse, Izidore S. Lossos, Brad S. Kahl, Peter Martin, Christopher R. Flowers, James R. Cerhan, Amylou C Dueck
Journal: Blood
Blood (2024) 144 (Supplement 1): 2345.
https://doi.org/10.1182/blood-2024-210594
Published: 2024
Journal Articles

Financial Toxicity, Health-Related Quality of Life, and Medication Adherence Patient-Reported Outcomes (PROs) in Patients with Chronic Lymphocytic Leukemia (CLL) on First-Line Oral Oncolytics

Jessica M Allen, Keegan Carroll, Dennis Gurfinkel, Caroline Tietbohl, Brooke Dorsey Holliman, Joseph Krongold, Jamie L Studts, Fay Hlubocky, Christopher K Daugherty, Ajay Major
Journal: Blood
Blood (2024) 144 (Supplement 1): 2354.
https://doi.org/10.1182/blood-2024-198915
Published: 2024
Journal Articles

Longitudinal Patient-Reported Outcomes (PROs) in a Prospective Registry of CAR T-Cell Therapy Recipients

Ajay Major, Thomas Althaus, Benjamin Brewer, Sarah Schmiege, Justin Kline, Michael R. Bishop, Jamie L Studts, Paul Cook, Peter A. Riedell
Journal: Blood
Blood (2023) 142 (Supplement 1): 2387.
https://doi.org/10.1182/blood-2023-178398
Published: 2023
Journal Articles

Frontline Management Strategy and Quality of Life in Follicular Lymphoma: A Multi-Institutional Prospective Cohort Study

Mazie Tsang, Brie N. Noble, Côme Bommier, Carla Casulo, Carrie Thompson, Allison C. Rosenthal, Dai Chihara, Eric Mou, Urshila Durani, Annalynn M Williams, Michelle Hildebrandt, Kathleen Yost, Melissa C. Larson, Brianna Gysbers, Matthew J. Maurer, Susan L. Slager, Andrew L. Feldman, David L Jaye, Jon Tilburt, J. C. C. Villasboas, Ajay Major, Priyanka A Pophali, Talal Hilal, Yucai Wang, Timothy G. Call, Amber Koehler, Javier L. Munoz, Gita Thanarajasingam, Paul J Hampel, Sameer A. Parikh, Loretta J. Nastoupil, Thomas E. Witzig, Grzegorz S. Nowakowski, Stephen M Ansell, Jonathon B. Cohen, Thomas M. Habermann, Christopher Strouse, Izidore S. Lossos, Brad S. Kahl, Peter Martin, Christopher R. Flowers, James R. Cerhan, Amylou Constance Dueck
Journal: Blood
Blood (2023) 142 (Supplement 1): 3761.
https://doi.org/10.1182/blood-2023-188382
Published: 2023
Journal Articles

Early Peripheral Blood Minimal Residual Disease Status By NGS in Patients with Newly Diagnosed Multiple Myeloma (MM) on a Phase 2 Trial Receiving Elotuzumab, Carfilzomib, Lenalidomide, and Dexamethasone (Elo-KRd)

Ben A Derman, Tadeusz Kubicki, Heidi Simmons, Aimaz Afrough, Jeffrey A. Zonder, David L. Grinblatt, Larry D. Anderson, Jr., Andrew Kin, Sunil Narula, Shayan Rayani, Sandeep Gurbuxani, Theodore Karrison, Ken Jiang, Ajay Major, Jennifer H Cooperrider, Allison P. Jacob, Andrzej J Jakubowiak
Journal: Blood
Blood (2023) 142 (Supplement 1): 1982.
https://doi.org/10.1182/blood-2023-182410
Published: 2023
Journal Articles

Outcomes of Patients with Relapsed/Refractory Lymphoplasmacytic Lymphoma Treated with Venetoclax: A Multicenter Retrospective Analysis

Yazeed Sawalha, Shayna R Sarosiek, Rina Li Welkie, Sherif Seif, Shrinjaya Thapa, Saurabh Zanwar, Kirk Cahill, Rachel Treitman, Haikoo Shah, Shagun Arora, Georgios Pongas, Allison Winter, Ajay Major, Peter A. Riedell, Maria Lia Palomba, Prashant Kapoor, Ariel F. Grajales-Cruz, Kenneth H. Shain, Sheeba K. Thomas, Jorge J. Castillo
Journal: Blood
Blood (2023) 142 (Supplement 1): 3045.
https://doi.org/10.1182/blood-2023-187237
Published: 2023
Journal Articles

Final Analysis of a Phase 2 Trial of Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Newly Diagnosed Multiple Myeloma (NDMM) without Autologous Stem Cell Transplantation (ASCT)

Benjamin A Derman, Jennifer H Cooperrider, Jacalyn Rosenblatt, David Avigan, Murtuza M. Rampurwala, Ajay Major, Theodore Karrison, Ken Jiang, Tadeusz Kubicki, Andrzej J Jakubowiak
Journal: Blood
Blood (2023) 142 (Supplement 1): 4747.
https://doi.org/10.1182/blood-2023-185309
Published: 2023
Journal Articles

Allogeneic Stem Cell Transplant and CD30 Directed CART Cell Therapies Are Associated with Improved Survival in Classical Hodgkin Lymphoma Refractory or Intolerant to Brentuximab Vedotin and Anti-PD-1 Therapy: Real World Analysis from 14 U.S. Academic Centers

Timothy Voorhees, Natalie S. Grover, Eric McLaughlin, Jorge A Florindez, Tamara K. Moyo, Heather Reves, Nuttavut Sumransub, Saarang Deshpande, Ashley Rose, Cassandra Duarte, Muhammad Salman Faisal, Showkat Hamid, Suki Subbiah, Sabarish R. Ayyappan, Lauren Kelly Shea, Matthew J Cortese, Krish Patel, Ajay Major, Hayder Saeed, Jakub Svoboda, Sanjal H. Desai, Praveen Ramakrishnan Geethakumari, Pallawi Torka, Narendranath Epperla
Journal: Blood
Blood (2023) 142 (Supplement 1): 900.
https://doi.org/10.1182/blood-2023-182385
Published: 2023
Journal Articles

Outcomes in Patients with Classical Hodgkin Lymphoma Refractory or Intolerant to Brentuximab Vedotin and Anti-PD-1 Therapy: Real World Analysis from 14 U.S. Academic Centers

Timothy Voorhees, Eric McLaughlin, Pallawi Torka, Jorge A Florindez, Tamara K. Moyo, Heather Reves, Nuttavut Sumransub, Saarang Deshpande, Ashley Rose, Cassandra Duarte, Muhammad Salman Faisal, Showkat Hamid, Suki Subbiah, Sabarish R. Ayyappan, Lauren Kelly Shea, Matthew J Cortese, Krish Patel, Ajay Major, Hayder Saeed, Jakub Svoboda, Sanjal H. Desai, Praveen Ramakrishnan Geethakumari, Natalie S. Grover, Narendranath Epperla
Journal: Blood
Blood (2023) 142 (Supplement 1): 3061.
https://doi.org/10.1182/blood-2023-181056
Published: 2023
Journal Articles

Molecular MRD By Digital PCR Is Prognostic of Outcomes in AML Patients on Intensive and Non-Intensive Treatment Regimens

Mohd Minhajuddin, Mohd Minhajuddin, Brett M. Stevens, Ajay Major, Nicholas Miltgen, Ji Yuan, Amy Treece, Jonathan A. Gutman, Craig T Jordan, Daniel A. Pollyea
Journal: Blood
Blood (2022) 140 (Supplement 1): 6274–6275.
https://doi.org/10.1182/blood-2022-167856
Published: 2022
Journal Articles

CNS Relapse in T-Cell Lymphoma Index: A Risk Score to Predict Central Nervous System Relapse in Patients with T-Cell Lymphomas

Rahul S. Bhansali, Fredrik Ellin, Miao Cao, Thomas Relander, Wenrui Li, Qi Long, Nivetha Ganesan, Robert Stuver, Steven M. Horwitz, Kitsada Wudhikarn, Steven R Hwang, N. Nora Bennani, Julio C. Chavez, Lubomir Sokol, Hayder Saeed, Frank Duan, Pierluigi Porcu, Priyanka Pullarkat, Neha Mehta-Shah, Jasmine Zain, Miguel Ruiz, Jonathan E Brammer, Rishab Prakash, Swami P. Iyer, Adam J. Olszewski, Ajay Major, Sonali M. Smith, Peter A. Riedell, Caroline Goldin, Bradley M. Haverkos, Bei Hu, Pamela B. Allen, Wael Toama, Murali Janakiram, Taylor Brooks, Deepa Jagadeesh, Nisha Hariharan, Aaron M Goodman, Paola Ghione, Fatima Fayyaz, Joanna M. Rhodes, Elise A. Chong, James N. Gerson, Daniel J. Landsburg, Sunita Dwivedy Nasta, Stephen J. Schuster, Jakub Svoboda, Mats Jerkeman, Stefan K. Barta
Journal: Blood
Blood (2022) 140 (Supplement 1): 1481–1484.
https://doi.org/10.1182/blood-2022-160090
Published: 2022
Journal Articles

Poor Survival Outcomes of Checkpoint Inhibitors for B-Cell Lymphomas Relapsing after or Refractory to CAR T-Cell Therapy: A Real-World Cohort from 15 U.S. Academic Institutions

Ajay Major, Jovian Yu, Navika D. Shukla, Rachel Treitman, Manali K. Kamdar, Bradley M. Haverkos, James Godfrey, Melissa A. Babcook, Timothy J. Voorhees, Sophie G Carlson, Daria Gaut, Caspian Oliai, Jason T. Romancik, Allison Winter, Brian T. Hill, Radhika Bansal, Jose C. Villasboas, Imran A. Nizamuddin, Reem Karmali, Lindsey A. Fitzgerald, Deborah M. Stephens, Priyanka A. Pophali, Asaad Trabolsi, Jonathan H. Schatz, Marie Hu, Veronika Bachanova, Michael J Slade, Nathan Singh, Nausheen Ahmed, Joseph P. McGuirk, Michael R. Bishop, Peter A. Riedell, Justin Kline
Journal: Blood
Blood (2022) 140 (Supplement 1): 1328–1331.
https://doi.org/10.1182/blood-2022-157829
Published: 2022
Journal Articles

Prospective Trial Using Multimodal Measurable Residual Disease Negativity to Guide Discontinuation of Maintenance Therapy in Multiple Myeloma (MRD2STOP)

Ben A. Derman, Ajay Major, Sarah Major, Brittany D. Wolfe, Martha Gorski, Jennifer H. Cooperrider, Evangelia Andreatos, Ken Jiang, Karson Buckley, Amanda McIver, Andrew Stefka, Andrzej Jakubowiak
Journal: Blood
Blood (2022) 140 (Supplement 1): 2108–2109.
https://doi.org/10.1182/blood-2022-158643
Published: 2022
Journal Articles

Need for Dynamic Frailty Risk Assessment Among Older Adults with Multiple Myeloma: A Population-Based Cohort Study

Hira S Mian, Tanya Wildes, Ravi Vij, Ajay Major, Mark A Fiala
Journal: Blood
Blood (2022) 140 (Supplement 1): 423–424.
https://doi.org/10.1182/blood-2022-158277
Published: 2022
Journal Articles

Global Health Status Inadequately Captures Longitudinal Changes in Quality of Life in Patients Receiving Carfilzomib for Multiple Myeloma: Electronic Patient-Reported Outcomes (ePROs) from a Prospective Observational Study

Ajay Major, Nicole Prabhu, Claire Cunningham, Jennifer H. Cooperrider, Hannah Johnston, Evangelia Andreatos, Martha Gorski, Sarah Major, Brittany D. Wolfe, Eric Kruse, Ben A. Derman, Roberto M. Lang, Andrzej Jakubowiak, Jeanne DeCara
Journal: Blood
Blood (2022) 140 (Supplement 1): 12593–12595.
https://doi.org/10.1182/blood-2022-157795
Published: 2022